L Daniel Browne - Net Worth and Insider Trading
L Daniel Browne Net Worth
The estimated net worth of L Daniel Browne is at least $573,056 dollars as of 2024-11-29. L Daniel Browne is the CEO and President of Revance Therapeutics Inc and owns about 151,602 shares of Revance Therapeutics Inc (RVNC) stock worth over $573,056. Details can be seen in L Daniel Browne's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that L Daniel Browne has not made any transactions after 2019-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of L Daniel Browne
L Daniel Browne Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, L Daniel Browne owns 1 companies in total, including Revance Therapeutics Inc (RVNC) .
Click here to see the complete history of L Daniel Browne’s form 4 insider trades.
Insider Ownership Summary of L Daniel Browne
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2019-03-18 | director & CEO and President |
L Daniel Browne Latest Holdings Summary
L Daniel Browne currently owns a total of 1 stock. L Daniel Browne owns 151,602 shares of Revance Therapeutics Inc (RVNC) as of March 18, 2019, with a value of $573,056.
Latest Holdings of L Daniel Browne
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RVNC | Revance Therapeutics Inc | 2019-03-18 | 151,602 | 3.78 | 573,056 |
Holding Weightings of L Daniel Browne
L Daniel Browne Form 4 Trading Tracker
According to the SEC Form 4 filings, L Daniel Browne has made a total of 0 transactions in Revance Therapeutics Inc (RVNC) over the past 5 years. The most-recent trade in Revance Therapeutics Inc is the sale of 11,613 shares on March 18, 2019, which brought L Daniel Browne around $180,118.
Insider Trading History of L Daniel Browne
- 1
L Daniel Browne Trading Performance
L Daniel Browne Ownership Network
L Daniel Browne Owned Company Details
What does Revance Therapeutics Inc do?
Who are the key executives at Revance Therapeutics Inc?
L Daniel Browne is the director & CEO and President of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .
Revance Therapeutics Inc (RVNC) Insider Trades Summary
Over the past 18 months, L Daniel Browne made no insider transaction in Revance Therapeutics Inc (RVNC). Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 53,837 shares made by Mark J Foley , a net sale of 14,263 shares made by Tobin Schilke , and a net sale of 42,978 shares made by Dwight Moxie .
In summary, during the past 3 months, insiders sold 3,908 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 3,908 shares. During the past 18 months, 164,089 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 134,089 shares.
Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Revance Therapeutics Inc Insider Transactions
L Daniel Browne Mailing Address
Above is the net worth, insider trading, and ownership report for L Daniel Browne. You might contact L Daniel Browne via mailing address: 7555 Gateway Boulevard, Newark Ca 94560.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
